Publicacións nas que colabora con ALVARO HERMIDA AMEIJEIRAS (18)

2023

  1. Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers

    Antioxidants, Vol. 12, Núm. 4

  2. Implications of Inflammatory and Oxidative Stress Markers in the Attenuation of Nocturnal Blood Pressure Dipping

    Journal of Clinical Medicine, Vol. 12, Núm. 4

2022

  1. Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications in the medium and long term

    PloS one, Vol. 17, Núm. 10, pp. e0268871

  2. Correlation between Blunted Nocturnal Decrease in Diastolic Blood Pressure and Oxidative Stress: An Observational Study

    Antioxidants, Vol. 11, Núm. 12

2021

  1. Celia’s encephalopathy (Bscl2-gene-related): Current understanding

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  2. Familial partial lipodystrophy syndromes

    Presse Medicale

  3. Lipodistrofia Parcial Familiar tipo 2: a propósito de un caso

    Galicia Clínica, Vol. 82, Núm. 1, pp. 33-35

  4. Variable expressivity and allelic heterogeneity in type 2 familial partial lipodystrophy: The p.(thr528met) lmna variant

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  5. Variable expressivity in type 2 familial partial lipodystrophy related to r482 and n466 variants in the lmna gene

    Journal of Clinical Medicine, Vol. 10, Núm. 6, pp. 1-9

2020

  1. LipoDDx: A mobile application for identification of rare lipodystrophy syndromes

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

2006

  1. Study on the ability of 1,2,3/4-tetrahydropapaveroline to cause oxidative stress: Mechanisms and potential implications in relation to Parkinson's disease

    Journal of Biochemical and Molecular Toxicology, Vol. 20, Núm. 5, pp. 209-220

2004

  1. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: Role of ferrous and ferric ions

    Neurochemistry International, Vol. 45, Núm. 1, pp. 103-116

2003

  1. Estudio del estrés oxidativo producido por el metabolismo y la autooxidación de la dopamina y sus efectos sobre las mitocondrias cerebrales: implicaciones en la enfermedad de Parkinson

    Estudio del estrés oxidativo producido por el metabolismo y la autooxidación de la dopamina y sus efectos sobre las mitocondrias cerebrales: implicaciones en la enfermedad de Parkinson

2002

  1. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: Relevance for Parkinson's disease

    Biochemical Pharmacology, Vol. 64, Núm. 1, pp. 125-135

  2. Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: Relevance for the pathogenesis of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1586, Núm. 2, pp. 155-168

2001

  1. Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: Mediation of antioxidants

    Free Radical Biology and Medicine, Vol. 31, Núm. 8, pp. 986-998

  2. Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals potential implications in relation to oxidative stress

    Life Sciences, Vol. 69, Núm. 8, pp. 879-889

2000

  1. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: Potential implication in relation to the pathogenesis of Parkinson's disease

    Journal of Neurochemistry, Vol. 74, Núm. 4, pp. 1605-1612